Literature DB >> 22144193

Agilent microRNA microarray profiling system.

Petula N D'Andrade1, Stephanie Fulmer-Smentek.   

Abstract

MicroRNA (miRNA) profiling is of great interest because of the significant roles these short noncoding RNA molecules play in cellular regulation. Signature profiles, usually involving several miRNAs, have also been associated with dysfunctional cellular regulation such as in cancer. Profiling miRNAs can be done using the Agilent Technologies miRNA profiling system, which is a sensitive and accurate miRNA microarray assay. The assay is based on a highly efficient labeling method linked to a novel probe design strategy. The labeling method uses a simple, single-vial approach where 100 ng of nonfractionated total RNA is directly labeled by ligation of a Cy3 labeled pCp molecule to the 3' end of the RNA. The labeled cytosine interacts with the guanidine at the 5' end of the probe which adds stability to the hybridization complex. In addition, the probes have been designed to provide both sequence and size discrimination, generally resulting in highly specific detection of closely related mature miRNAs. The labeling and probe design strategies allow for a precise and accurate measurement that spans a linear dynamic range of greater than four orders of magnitude from at least 0.2 amol to 2 fmol of miRNA and a detection limit of less than 0.1 amol. The assay works over a wide range of sample types including FFPE samples. Agilent's microarray technology is a flexible design platform allowing quick array design iterations and incorporation of the latest miRBase content.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22144193     DOI: 10.1007/978-1-61779-427-8_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  5 in total

1.  Differential expression of miR-139, miR-486 and miR-21 in breast cancer patients sub-classified according to lymph node status.

Authors:  Lene Rask; Eva Balslev; Rolf Søkilde; Estrid Høgdall; Henrik Flyger; Jens Eriksen; Thomas Litman
Journal:  Cell Oncol (Dordr)       Date:  2014-07-16       Impact factor: 6.730

Review 2.  Mini but mighty: microRNAs in the pathobiology of periodontal disease.

Authors:  Moritz Kebschull; Panos N Papapanou
Journal:  Periodontol 2000       Date:  2015-10       Impact factor: 7.589

3.  Guanine-Rich Sequences Are a Dominant Feature of Exosomal microRNAs across the Mammalian Species and Cell Types.

Authors:  Fumiyasu Momose; Naohiro Seo; Yasushi Akahori; Shin-Ichi Sawada; Naozumi Harada; Toru Ogura; Kazunari Akiyoshi; Hiroshi Shiku
Journal:  PLoS One       Date:  2016-04-21       Impact factor: 3.240

4.  miR-16-5p Is a Stably-Expressed Housekeeping MicroRNA in Breast Cancer Tissues from Primary Tumors and from Metastatic Sites.

Authors:  Gabriel Rinnerthaler; Hubert Hackl; Simon Peter Gampenrieder; Frank Hamacher; Clemens Hufnagl; Cornelia Hauser-Kronberger; Franz Zehentmayr; Gerd Fastner; Felix Sedlmayer; Brigitte Mlineritsch; Richard Greil
Journal:  Int J Mol Sci       Date:  2016-01-26       Impact factor: 5.923

Review 5.  How Are Epigenetic Modifications Related to Cardiovascular Disease in Older Adults?

Authors:  Mojgan Gharipour; Arya Mani; Mona Amini Baghbahadorani; Camila Kellen de Souza Cardoso; Shayesteh Jahanfar; Nizal Sarrafzadegan; Cesar de Oliveira; Erika Aparecida Silveira
Journal:  Int J Mol Sci       Date:  2021-09-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.